Tao Capital Management LP
Follow13F filer, CIK 1802967, SAN FRANCISCO, CA
Tao Capital Management LP reported $132,202,625 across 10 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-12.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001802967-25-000007
- Period
- 2025-09-30
- Reported value
- $132M
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TXGnew | +210,862 | $2.46M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MDGLreduced | -71,785 | -$32.9M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001802967-25-000007, largest first. % of portfolio is the value over $132,202,625, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| TSLATESLA INC | 86,250 | $38.4M | 29.01% | 0 | Timeline | ||
| OUSTOUSTER INC | 1,125,316 | $30.4M | 23.03% | 0 | Timeline | ||
| TWSTTWIST BIOSCIENCE CORP | 828,815 | $23.3M | 17.64% | 0 | Timeline | ||
| MDGLMADRIGAL PHARMACEUTICALS INC | 41,000 | $18.8M | 14.22% | -71,785 | Timeline | ||
| HHYATT HOTELS CORP | 70,000 | $9.94M | 7.52% | 0 | Timeline | ||
| MASS908 DEVICES INC | 568,981 | $4.98M | 3.77% | 0 | Timeline | ||
| WRBYWARBY PARKER INC | 134,473 | $3.71M | 2.81% | 0 | Timeline | ||
| TXG10X GENOMICS INC | 210,862 | $2.46M | 1.86% | new | Timeline | ||
| SONDQSONDER HLDGS INC CL A NEW | 80,188 | $102K | 0.08% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 5,683 | $82.9K | 0.06% | 0 | Timeline |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001802967-25-000007 | base | 2025-11-12 | acceptance time not in the bulk data set |